Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus challenges when combined with a mucosal adjuvant that enhances the body’s immune response, according to a study by researchers in the Institute for Biomedical Sciences at Georgia State University.



Summary

A Georgia State University study found that influenza hemagglutinin subunit vaccines are significantly improved by using mucosal adjuvants. These adjuvants boost the immune response, making the vaccines more effective and providing broader protection against diverse influenza virus strains. This suggests that incorporating mucosal adjuvants can lead to more robust and versatile flu vaccines than those using hemagglutinin subunit vaccines alone. The researchers highlight the potential for enhanced vaccine efficacy and cross-protection against various influenza challenges.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!